Evidence map

TrialCardiovascular diabetology2016

Rationale and design of a randomized trial to test the safety and non-inferiority of canagliflozin in patients with diabetes with chronic heart failure: the CANDLE trial.

Atsushi Tanaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

19 papers cite it

2016
2017
2018
2019
2020
2021
2022
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 27044332